We are a venture capital firm that helps founders tackle hard problems with capital, resources and collaboration.
We invest in pre-seed and seed companies that leverage breakthrough technology to digitize, automate and decarbonize the world.
Surge (HCVC'22) CLOSES 7.5M€ SEED ROUND
With new backing from Eurazeo, the Stanford spin-out will pursue its mission to decrypt the immune system and transform precision medicine.
Fighting Methane Emissions with better technology
Atmio closed €1.3m round led by HCVC for its Operating System to find, fix, and report methane leaks.
Backing Chiral's mission to extend Moore's Law
Chiral announces $3.8m round to build the future infrastructure for the industrial manufacturing of nano-transistors.
Transmutex (HCVC'22) closes $23m Series A to recycle nuclear waste
The company develops new design for a nuclear reactor that can produce energy and nuclear fuel from radioactive waste
Chef Robotics (HCVC'23) raises $14.5m to expand its autonomous kitchens
The company has seen revenue quadruple last year and plans ambitious expansion in 2024.
WELCOMING NUMI TO HCVC'S BIOMANUFACTURING PORTFOLIO
We’re excited to partner with Nūmi in a $3m Seed round to pioneer the development of cell-cultured breast milk.
OUR INVESTMENT IN LAMBDA AUTOMATA
Founded by former Apple and Palantir engineers, the company develops dual-use autonomous surveillance towers powered by AI.
BIOLOGY MEETS DATA TO CREATE THE FUTURE OF ONCOLOGY
Orakl announces seed round to accelerate cancer drug development with techbio platform that better models tumors.
AUTOMATA (HCVC'18) RAISES $40M LED BY DIMENSION
The new round will allow Automata to further expand Linq, its leading lab automation platform
ANNOUNCING THE CLOSING OF OUR NEW $75M HARDTECH FUND
Fund II will back world-class teams building breakthrough technologies at pre-seed and seed across Europe and North America